dendritic cell loaded with ofa
Vaccineexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2005 (NCT00125749)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dendritic cell loaded with ofa
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00715832 | Phase 1 | May 1, 2008 | Quantum Immunologics, Inc., Southern Cancer Center, University of South Alabama |
| NCT00879489 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | Quantum Immunologics, Inc., University of South Alabama |
| NCT00843830 | Phase 1 | Oct 1, 2006 | University of Michigan |
| NCT00125749 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2005 | Baylor University, Mary Crowley Cancer Center, ODC Therapy |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Quantum Immunologics, Inc. | For profit | 2 | 1 | 2 | 2008 |
| University of South Alabama | Academic/Hospital | 2 | 0 | 2 | 2008 |
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Mary Crowley Cancer Center | Academic/Hospital | 1 | 0 | 1 | 2005 |
| ODC Therapy | For profit | 1 | 0 | 1 | 2005 |
| Southern Cancer Center | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2006 |
7 organizations
Page 1 / 1